Anschutz Health and Wellness Center, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
Int J Obes (Lond). 2023 Sep;47(9):761-763. doi: 10.1038/s41366-023-01334-0. Epub 2023 Jul 6.
Transgender and gender diverse (TGD) adults are more likely to have obesity compared to cisgender peers. Based on surveys, the TGD population experiences disparities in healthy lifestyle behaviors (e.g., physical activity, screen time) compared to reference groups. They also face significant socioeconomic and healthcare barriers to accessing affirming care and gender minority stress, potentially contributing to increased weight. Gender-affirming hormone therapy is associated with changes in body composition and increased weight, which may impact cardiometabolic risk trajectory. Obesity can also be a barrier to gender-affirming surgeries, and affirming weight management services tailored to TGD patients are an important gap in healthcare to address. This Perspective briefly reviews current literature on the unique barriers experienced by TGD people and their identified needs regarding weight management interventions. It also suggests areas for future research to best fill this gap in healthcare and research while supporting the provision of lifesaving gender-affirming care.
跨性别和性别多样化（TGD）成年人比顺性别同龄人更有可能肥胖。基于调查，TGD 人群在健康生活方式行为（例如，体育锻炼、屏幕时间）方面与参考群体存在差异。他们在获得认可的护理和性别少数群体压力方面也面临着重大的社会经济和医疗保健障碍，这可能导致体重增加。性别肯定激素治疗与身体成分的变化和体重增加有关，这可能会影响心血管代谢风险轨迹。肥胖也可能成为性别肯定手术的障碍，为 TGD 患者量身定制的肯定体重管理服务是解决医疗保健中一个重要的空白领域。本观点简要回顾了当前关于 TGD 人群所经历的独特障碍以及他们在体重管理干预方面的确定需求的文献。它还提出了未来研究的领域，以最好地填补这一医疗保健和研究空白，同时支持提供拯救生命的性别肯定护理。
